Biogen Inc. (BIIB)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
286.00-4.78 (-1.64%)
At close: 4:00 PM EDT
People also watch:
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Prev Close290.78
Bid0.00 x
Ask0.00 x
Day's Range285.27 - 291.04
52wk Range223.02 - 333.65
1y Target EstN/A
Market Cap62.67B
P/E Ratio (ttm)16.71
Avg Vol (3m)1,558,309
Dividend & YieldN/A (N/A)
Earnings DateN/A
Trade prices are not sourced from all markets
  • American City Business Journals16 hours ago

    Here's the big news we're likely to hear when Vertex, Biogen report Q3 this week

    Earnings season for our Massachusetts biotech giants kicks off this week when Vertex Pharmaceuticals reports its third quarter financials on Tuesday evening, followed by Biogen on Wednesday morning. While probably just a fluke, it’s unusual for Vertex (VRTX) to be the first local biotech to give a quarterly update, as that honor usually goes to Biogen (BIIB). Vertex : To some extent, the financial news expected from the Boston-based company is already old news.

  • Drug Stock Earnings to Watch on Oct 26: BIIB, MDCO & More
    Zacks19 hours ago

    Drug Stock Earnings to Watch on Oct 26: BIIB, MDCO & More

    How will these four drug stocks, BIIB, EXAS, MDCO and ANIK, which are scheduled to report Q3 results on Oct 26, fare this earnings season?

  • GlobeNewswireyesterday

    Labaton Sucharow LLP Files Class Action Lawsuit on Behalf of Biogen Inc. Investors

    NEW YORK, Oct. 24, 2016-- Labaton Sucharow LLP announces that on October 20, 2016, it filed a securities class action lawsuit on behalf of its client Electrical Workers Pension Fund, Local 103, International ...